AWC
PPH icon

Adamsbrown Wealth Consultants’s VanEck Pharmaceutical ETF PPH Stock Holding History

Adamsbrown Wealth Consultants’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9M Buy
154,114
+5,303
+4% +$549K 3.18% 11
2026
Q1 		$15.5M Buy
148,811
+5,766
+4% +$614K 4.09% 7
2025
Q4 		$14.8M Buy
143,045
+6,146
+4% +$598K 4.11% 7
2025
Q3 		$12.4M Sell
136,899
-59,077
-30% -$5.17M 3.41% 10
2025
Q2 		$17.2M Buy
195,976
+21,074
+12% +$1.83M 5% 8
2025
Q1 		$15.9M Buy
174,902
+25,271
+17% +$2.28M 5.01% 7
2024
Q4 		$12.9M Buy
149,631
+75,659
+102% +$6.84M 4.4% 9
2024
Q3 		$7.03M Buy
+73,972
New +$7.03M 2.44% 12

Other funds holding PPH

FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
WF
Warner Financial Bethesda, Maryland $340M AUM 22.81% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
VIP
Value Investment Professionals New York $119M AUM
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CI
Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return
AT
Arlington Trust Birmingham, Alabama $1.18B AUM 11.55% 1-Year Est. Return

Adamsbrown Wealth Consultants's PPH Position: Q2 2026 in Review

Adamsbrown Wealth Consultants increased its VanEck Pharmaceutical ETF (PPH) stake by 3.6% in Q2 2026, buying an estimated $549K and bringing the position to 154,114 shares worth $16.9M. The position accounts for 3.18% of the portfolio, ranked #11.

Adamsbrown Wealth Consultants first reported a position in PPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $17.2M in Q2 2025. 14 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Adamsbrown Wealth Consultants held 154,114 shares of VanEck Pharmaceutical ETF worth $16.9M as of Q2 2026.
  • Adamsbrown Wealth Consultants bought 5,303 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $549K.
  • VanEck Pharmaceutical ETF made up 3.18% of Adamsbrown Wealth Consultants's portfolio in Q2 2026, its #11 holding.
  • Adamsbrown Wealth Consultants first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and has held it in 8 quarters since.
  • Adamsbrown Wealth Consultants's VanEck Pharmaceutical ETF position peaked at $17.2M in Q2 2025.
  • 14 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Adamsbrown Wealth Consultants's 13F filing for Q2 2026, filed 9 Jul 2026.